TIMS Gachibowli notifies walk-in-interviews to fill 199 clinical vacant posts
The list of vacant posts include 12 Professors, 23 Associate Professor, 22 Assistant Professors, 94 Medical Officers, one Nursing Superintendent Gr-II, six Assistant Deputy Nursing Superintendent/Head Nurse
Hyderabad: The Telangana Institute of Medical Sciences (TIMS), Gachibowli, has issued a notification to fill-up 199 vacant clinical and non-clinical posts on contract basis in the coming days. The interviews for these posts will be conducted from April 16 onwards.
The list of vacant posts include 12 Professors, 23 Associate Professor, 22 Assistant Professors, 94 Medical Officers, one Nursing Superintendent Gr-II, six Assistant Deputy Nursing Superintendent/Head Nurse, 32 posts of Staff Nurse, one Dietician and eight posts Pharmacist.
The medical departments for which the posts of Professor, Associate Professors and Assistant Professors are to be filled include Bio-Chemistry, Pathology, Microbiology, General Medicine, Tuberculosis and Chest Department (TBCD), Radiodiagnosis and Anaesthesia.
Walk-in-interviews will be conducted from 10 am to 3 pm on April 16 for the posts of Professor, Associate Professor, Assistant Professor, Nursing Superintendent Gr-II, Assistant Deputy Nursing Superintendent/Head Nurse and Dietician.
The walk-in-interviews for the posts of Staff Nurse and Pharmacists will be from 10 am to 3 pm on April 17 while interviews for Civil Assistant Surgeons or Medical Officers will be from 10 am to 3 pm on April 19, the TIMS notification said.
The monthly remuneration will be Rs.1.90 lakh for Professors, Rs 1.50 lakh for Associate Professors, Rs.1.25 lakh for Assistant Professors, Rs.40,270 for Medical Officers, Rs.35,120 for Nursing Superintendent, Rs. 29,760 for Assistant Deputy Nursing Superintendent, Rs. 25,140 to Staff Nurse, Rs.35,120 for Dietician and Rs. 21,230 for Pharmacists.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
